Diagnostic test accuracy of informant based tools to diagnose dementia in older hospital patients with delirium:a prospective cohort study by Jackson, Thomas et al.
 
 
Diagnostic test accuracy of informant based tools
to diagnose dementia in older hospital patients with
delirium
Jackson, Thomas; MacLullich, Alasdair MJ; Gladman, J; Lord, Janet; Sheehan, Bart
DOI:
10.1093/ageing/afw065
10.1093/ageing/afw065
License:
None: All rights reserved
Document Version
Peer reviewed version
Citation for published version (Harvard):
Jackson, T, MacLullich, AMJ, Gladman, J, Lord, J & Sheehan, B 2016, 'Diagnostic test accuracy of informant
based tools to diagnose dementia in older hospital patients with delirium: a prospective cohort study', Age and
Ageing, vol. 45, no. 4, pp. 505-511. https://doi.org/10.1093/ageing/afw065,
https://doi.org/10.1093/ageing/afw065
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
Eligibility for repository: Checked on 8/3/2016
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Feb. 2019
Supplementary Figure 1 
Receiver operating characteristic curves (ROC) for patients with delirium (N=77) to diagnose 
dementia 
AUROC = area under the ROC curve, reference line = line where AUROC is 0.50 
 
  
Supplementary Appendix 1:  Power calculations 
The primary aim of the study was to evaluate the diagnostic accuracy of the IQCODE-SF and 
AD8 against a reference standard diagnosis, and the sample size calculation was based on 
this. The power calculation was based on the method recommended by Guyatt et al [1] using 
a predicated sensitivity of the IQCODE-SF of 80%, and allowing a 95% confidence intervals 
no wider than 10%. Using the formula 0.1=1.96×√pq÷n where p=the proportion of target-
positive patients with a positive test result, and q=1-p, 62 patients with a diagnosis of 
dementia would be needed. Assuming half of those with delirium had undiagnosed dementia 
our sample size was calculated at 124. 
 
[1] Guyatt GHS, D. L. Haynes, R.B. Evaluating Diagnostic Tests. In: Haynes RBS, D. L. 
Guyatt, G. H. Tugwell, P., editor. Clinical Epidemiology: How to do clinical practice 
research 3rd ed. Philadelphia: LWW; 2005. 
  
Supplementary Appendix 2: STARD Checklist and Flowchart 
 
STARD checklist for reporting of studies of diagnostic accuracy 
(version January 2003) 
 
 
Section and Topic Item 
# 
 On page # 
TITLE/ABSTRACT/ 
KEYWORDS 
1 Identify the article as a study of diagnostic accuracy (recommend MeSH 
heading 'sensitivity and specificity'). 
1,4 
INTRODUCTION 2 State the research questions or study aims, such as estimating diagnostic 
accuracy or comparing accuracy between tests or across participant 
groups. 
8 
METHODS    
Participants 3 The study population: The inclusion and exclusion criteria, setting and 
locations where data were collected. 
8 
 4 Participant recruitment: Was recruitment based on presenting symptoms, 
results from previous tests, or the fact that the participants had received 
the index tests or the reference standard? 
8 
 5 Participant sampling: Was the study population a consecutive series of 
participants defined by the selection criteria in item 3 and 4? If not, 
specify how participants were further selected. 
8 
 6 Data collection: Was data collection planned before the index test and 
reference standard were performed (prospective study) or after 
(retrospective study)? 
8-9 
Test methods 7 The reference standard and its rationale. 11 
 8 Technical specifications of material and methods involved including how 
and when measurements were taken, and/or cite references for index 
tests and reference standard. 
10 
 9 Definition of and rationale for the units, cut-offs and/or categories of the 
results of the index tests and the reference standard. 
10,11 
 10 The number, training and expertise of the persons executing and reading 
the index tests and the reference standard. 
11 
 11 Whether or not the readers of the index tests and reference standard 
were blind (masked) to the results of the other test and describe any 
other clinical information available to the readers. 
10 
Statistical methods 12 Methods for calculating or comparing measures of diagnostic accuracy, 
and the statistical methods used to quantify uncertainty (e.g. 95% 
confidence intervals). 
10,11 
 13 Methods for calculating test reproducibility, if done. NA 
RESULTS    
Participants 14 When study was performed, including beginning and end dates of 
recruitment. 
12 
 15 Clinical and demographic characteristics of the study population (at least 
information on age, gender, spectrum of presenting symptoms). 
12, fig 1 
 16 The number of participants satisfying the criteria for inclusion who did or 
did not undergo the index tests and/or the reference standard; describe 
why participants failed to undergo either test (a flow diagram is strongly 
recommended). 
12, fig1 
Test results 17 Time-interval between the index tests and the reference standard, and 
any treatment administered in between. 
8 
 18 Distribution of severity of disease (define criteria) in those with the target 
condition; other diagnoses in participants without the target condition. 
NA 
 19 A cross tabulation of the results of the index tests (including 
indeterminate and missing results) by the results of the reference 
standard; for continuous results, the distribution of the test results by the 
results of the reference standard. 
Table 1 
 20 Any adverse events from performing the index tests or the reference 
standard. 
NA 
Estimates 21 Estimates of diagnostic accuracy and measures of statistical uncertainty 
(e.g. 95% confidence intervals). 
12,13,table 
1 
 22 How indeterminate results, missing data and outliers of the index tests 
were handled. 
NA 
 23 Estimates of variability of diagnostic accuracy between subgroups of 
participants, readers or centers, if done. 
NA 
 24 Estimates of test reproducibility, if done.      NA 
DISCUSSION 25 Discuss the clinical applicability of the study findings. Fig 2 
 
 
 
Eligible 
patients 
Index test 
Abnormal result Normal result 
n=55 
Reference standard 
n=32 
Reference standard 
n=45 
Target 
condition 
absent 
n=2 
Target 
condition 
present 
n=43 
Target 
condition 
present 
n=4 
Target 
condition 
absent 
n=28 
Excluded patients 
(total 79): 
Consultee unavailable: 
57 
Palliative care: 22 
Communication: 15 
Consultee declined 
participation: 2 
Previously recruited: 7 
No reference 
standard 
n=25 
Died: 12 
No f/u: 9 
Persistent 
delirium: 4 
 
No reference 
standard 
n=23 
Died: 13 
No f/u: 9 
Persistent 
delirium: 1 
